MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a patient’s bloodstream. MBF is an extracorporeal technology, similar to dialysis. A patient's blood is continuouslycirculated through an external blood loop containing the MediSieve system. Targeted magnetic particles (TB-MPs) are infused into the loop, binding specifically to disease-relevant targets in the patient's blood. The blood then flows through a magnetic filter which captures the particles and bound targets and the remainder of the blood returns to the patient unaffected; the TB-MPs never enter the patient’s body.MediSieve is based at the Imperial Incubator in White City, London. It has dedicated workshop and laboratory facilities (including capacity for ELISAs, Flow Cytometry and human blood testing) in which products are developed and validated.

Biotechnology

Health Care

Therapeutics

MediSieve

MediSieve's headquarters in London, United Kingdom

George Frodsham

Elinor Jones

Cristina Blanco-Andujar

This department conducts research and analysis in biological sciences to support health and safety outcomes.

Laboratory Sciences

This department is responsible for ensuring that products and services meet established quality standards and regulatory requirements.

Quality Assurance

This department provides strategic direction and oversees overall operations of the organization.

MediSieve

Org chart

Teams

Laboratory Sciences

Quality Assurance

Executive Leadership

Offices

MediSieve

Org chart

Teams

Laboratory Sciences

Quality Assurance

Executive Leadership

Offices

Related companies